Research and Markets: Global Retinopathy Partnering Deals 2009-2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/fc4c6h/retinopathy) has announced the addition of the "Retinopathy Partnering 2009-2014" report to their offering.

Retinopathy Partnering 2009-2014 report provides understanding and access to the retinopathy partnering deals and agreements entered into by the world's leading healthcare companies.

  • Trends in retinopathy partnering deals
  • Top retinopathy deals by value
  • Deals listed by company A-Z, industry sector, stage of development, technology type

Retinopathy Partnering 2009-2014 provides understanding and access to the retinopathy partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of retinopathy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors retinopathy technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of retinopathy technologies and products.

Report scope

Retinopathy Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to retinopathy trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

  • Trends in retinopathy dealmaking in the biopharma industry since 2009
  • Access to summary headline, upfront, milestone and royalty data
  • The leading retinopathy deals by value since 2009

In Retinopathy Partnering 2009-2014, the available deals are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Company A-Z
  • Industry sector
  • Stage of development at signing
  • Deal component type
  • Technology type

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in Retinopathy partnering

  • Retinopathy partnering over the years
  • Bigpharma Retinopathy dealmaking activity
  • Retinopathy partnering by deal type
  • Retinopathy partnering industry sector
  • Retinopathy partnering by stage of development
  • Retinopathy partnering by technology type
  • Disclosed financial deal terms for Retinopathy partnering

Chapter 3 - Leading Retinopathy deals

  • Top Retinopathy deals by value
  • Top Retinopathy deals involving bigpharma

Chapter 4 - Dealmaking directory

  • Company A-Z
  • By deal type
  • By industry sector
  • By stage of development
  • By technology type

Chapter 5 - Partnering resource center

  • Online partnering
  • Partnering events
  • Further reading on dealmaking

For more information visit http://www.researchandmarkets.com/research/fc4c6h/retinopathy

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices